Susan Bobulsky is Chief Commercial Officer, MRD of Adaptive Biotechnologies Corp. Currently has a direct ownership of 248,290 shares of ADPT, which is worth approximately $878,946. The most recent transaction as insider was on Mar 05, 2024, when has been sold 12,991 shares (Common Stock) at a price of $3.44 per share, resulting in proceeds of $44,689. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 248K
0% 3M change
2611.18% 12M change
Total Value Held $878,946

SUSAN BOBULSKY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$44,689 $3.44 p/Share
12,991 Reduced 4.97%
248,290 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
132,979 Added 33.73%
261,281 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
9,158 Added 50.0%
9,158 Common Stock
Dec 10 2020
SELL
Open market or private sale
$1,375,000 $55.0 p/Share
25,000 Reduced 100.0%
0 Common Stock
Dec 10 2020
BUY
Exercise of conversion of derivative security
$49,500 $1.98 p/Share
25,000 Added 50.0%
25,000 Common Stock
Sep 29 2020
SELL
Open market or private sale
$500,000 $50.0 p/Share
10,000 Reduced 100.0%
0 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$19,800 $1.98 p/Share
10,000 Added 50.0%
10,000 Common Stock
SB

Susan Bobulsky

Chief Commercial Officer, MRD
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT